Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792369 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

26DT052; Scaling Busulfan Dose to Body Surface Area in Children

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this pilot study is to determine if scaling the first busulfan dose to Body Surface Area (BSA) in children with a BSA ≥0.5 m2 and using a BSA-banded dosing table for infants (BSA \<0.5 m2) increases the fraction of patients achieving a therapeutic drug exposure after the first dose.
Trial Details
NCT Number NCT07792369
Lead Sponsor Children's Hospital of Philadelphia
Collaborators: Alex's Lemonade Stand Foundation
Conditions
(from sponsor)		 Busulfan Pharmacokinetic Analysis, Busulfan Dosing, Hematopoietic Stem Cell Transplant (HSCT), Busulfan, Glutathione
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov